Literature DB >> 20724682

Antiretroviral therapy as HIV prevention: status and prospects.

Kenneth H Mayer1, Kartik K Venkatesh.   

Abstract

As antiretroviral treatment of HIV infection has become increasingly accessible, attention has focused on whether these drugs can used for prevention because of increased tolerability of newer medications, decreased cost, and the limitations of other approaches. We review the status of antiretroviral HIV prevention, including chemoprophylaxis, as well as the effects of treatment of infected individuals on prevention. It is possible that the life-saving agents that have transformed the natural history of AIDS can be a critical component of HIV prevention efforts, but their ultimate role in affecting HIV transmission dynamics remains to be defined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724682      PMCID: PMC2936983          DOI: 10.2105/AJPH.2009.184796

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  113 in total

Review 1.  Antiretroviral drug concentrations in semen of HIV-1 infected men.

Authors:  S Taylor; A S Pereira
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

2.  Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men.

Authors:  T M Lampinen; C W Critchlow; J M Kuypers; C S Hurt; P J Nelson; S E Hawes; R W Coombs; K K Holmes; N B Kiviat
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

3.  Modelling the effect of combination antiretroviral treatments on HIV incidence.

Authors:  M G Law; G Prestage; A Grulich; P Van de Ven; S Kippax
Journal:  AIDS       Date:  2001-07-06       Impact factor: 4.177

Review 4.  Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention.

Authors:  J A Kelly; L L Otto-Salaj; K J Sikkema; S D Pinkerton; F R Bloom
Journal:  Health Psychol       Date:  1998-07       Impact factor: 4.267

5.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

6.  Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials.

Authors:  Ravindra Gupta; Andrew Hill; Anthony W Sawyer; Deenan Pillay
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

7.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

Review 8.  Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.

Authors:  Kimberly A Powers; Charles Poole; Audrey E Pettifor; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2008-08-04       Impact factor: 25.071

Review 9.  Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV.

Authors:  Ingrid V Bassett; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2004-07-16       Impact factor: 9.079

10.  Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.

Authors:  J J Eron; P L Vernazza; D M Johnston; F Seillier-Moiseiwitsch; T M Alcorn; S A Fiscus; M S Cohen
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

View more
  36 in total

Review 1.  Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.

Authors:  Kartik K Venkatesh; Timothy P Flanigan; Kenneth H Mayer
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

2.  Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Lisa A Eaton; James J Kohler; Catherine Montero; Raymond F Schinazi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

3.  Preserving human rights in the era of "test and treat" for HIV prevention.

Authors:  Jeannia J Fu; Alexander R Bazazi; Frederick L Altice
Journal:  Am J Public Health       Date:  2011-02       Impact factor: 9.308

4.  Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.

Authors:  Farah Ladak; Eugenia Socias; Seonaid Nolan; Huiru Dong; Thomas Kerr; Evan Wood; Julio Montaner; M-J Milloy
Journal:  Antivir Ther       Date:  2019

5.  Comparison of auditory brainstem response in HIV-1 exposed and unexposed newborns and correlation with the maternal viral load and CD4+ cell counts.

Authors:  Ayotunde James Fasunla; Babatunde Oluwatosin Ogunbosi; Georgina Njideka Odaibo; Onyekwere George Benjamin Nwaorgu; Babafemi Taiwo; David Olufemi Olaleye; Kikelomo Osinusi; Robert Leo Murphy; Isaac Folorunso Adewole; Olusegun Olusina Akinyinka
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

6.  Project enhance: a randomized controlled trial of an individualized HIV prevention intervention for HIV-infected men who have sex with men conducted in a primary care setting.

Authors:  Steven A Safren; Conall M O'Cleirigh; Margie Skeer; Steven A Elsesser; Kenneth H Mayer
Journal:  Health Psychol       Date:  2012-07-02       Impact factor: 4.267

7.  Experience in international clinical research: the HIV Prevention Trials Network.

Authors:  Nirupama Deshmane Sista; Quarraisha Abdool Karim; Kathy Hinson; Deborah Donnell; Susan H Eshleman; Sten H Vermund
Journal:  Clin Investig (Lond)       Date:  2011-12

8.  Immune-mediated attenuation of HIV-1.

Authors:  Denis R Chopera; Jaclyn K Wright; Mark A Brockman; Zabrina L Brumme
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

Review 9.  HIV prevention transformed: the new prevention research agenda.

Authors:  Nancy S Padian; Sandra I McCoy; Salim S Abdool Karim; Nina Hasen; Julia Kim; Michael Bartos; Elly Katabira; Stefano M Bertozzi; Bernhard Schwartländer; Myron S Cohen
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

Review 10.  Antiviral agents and HIV prevention: controversies, conflicts, and consensus.

Authors:  Myron S Cohen; Kathryn E Muessig; M Kumi Smith; Kimberly A Powers; Angela D M Kashuba
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.